Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

CD19-CART Cells in the Treatment of CD19+ r/r B Cell-derived Hematological Malignancies

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04184414
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:29.806822+00:00
Published At
2019-12-03T00:00:00+00:00
Record Updated At
2019-12-03
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["B Acute Lymphoblastic Leukemia", "Mantle Cell Lymphoma", "Follicular Lymphoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-12-03"
protocolSection.identificationModule.nctId
"NCT04184414"
protocolSection.identificationModule.officialTitle
"CD19-CART Cells in the Treatment of CD19+ r/r B Cell-derived Hematological Malignancies"
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
["EARLY_PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • B Acute Lymphoblastic Leukemia (protocolSection.conditionsModule.conditions)
  • Mantle Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Follicular Lymphoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.